Literature DB >> 19457338

Design of high-density antibody microarrays for disease proteomics: key technological issues.

Carl A K Borrebaeck1, Christer Wingren.   

Abstract

Antibody-based microarray is a novel proteomic technology setting a new standard for molecular profiling of non-fractionated complex proteomes. The first generation of antibody microarrays has already demonstrated its potential for generating detailed protein expression profiles, or protein atlases, of human body fluids in health and disease, paving the way for new discoveries within the field of disease proteomics. The process of designing highly miniaturized, high-density and high-performing antibody microarray set-ups have, however, proven to be challenging. In this mini-review we discuss key technological issues that must be addressed in a cross-disciplinary manner before true global proteome analysis can be performed using antibody microarrays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457338     DOI: 10.1016/j.jprot.2009.01.027

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  33 in total

Review 1.  Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer.

Authors:  Carl A K Borrebaeck
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

2.  The effects of tether placement on antibody stability on surfaces.

Authors:  Rebecca W Grawe; Thomas A Knotts
Journal:  J Chem Phys       Date:  2017-06-07       Impact factor: 3.488

3.  Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

Authors:  Anders Carlsson; Christer Wingren; Malin Kristensson; Carsten Rose; Mårten Fernö; Håkan Olsson; Helena Jernström; Sara Ek; Elin Gustavsson; Christian Ingvar; Mattias Ohlsson; Carsten Peterson; Carl A K Borrebaeck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 4.  Pathogenesis of contact lens-associated microbial keratitis.

Authors:  Suzanne M J Fleiszig; David J Evans
Journal:  Optom Vis Sci       Date:  2010-04       Impact factor: 1.973

5.  Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries.

Authors:  Lutz Kummer; Petra Parizek; Peter Rube; Bastian Millgramm; Anke Prinz; Peer R E Mittl; Melanie Kaufholz; Bastian Zimmermann; Friedrich W Herberg; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-27       Impact factor: 11.205

6.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

Review 7.  Yeast proteomics and protein microarrays.

Authors:  Rui Chen; Michael Snyder
Journal:  J Proteomics       Date:  2010-08-20       Impact factor: 4.044

8.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

9.  Leptospiral outer membrane protein microarray, a novel approach to identification of host ligand-binding proteins.

Authors:  Marija Pinne; James Matsunaga; David A Haake
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

10.  Protein Microarrays for Ocular Diseases.

Authors:  Guillermo Solís-Fernández; Ana Montero-Calle; Miren Alonso-Navarro; Miguel Ángel Fernandez-Torres; Victoria Eugenia Lledó; María Garranzo-Asensio; Rodrigo Barderas; Ana Guzman-Aranguez
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.